Fierce Pharma September 18, 2024
Andrea Park

No longer a far-off futuristic idea, artificial intelligence technology has seen its popularity skyrocket in recent years. Its usage continues to grow rapidly and exponentially: According to IBM’s most recent Global AI Adoption Index report, around 42% of large businesses are actively using AI, up from 35% just one year prior and 31% the year before that.

Amid all the AI hype, pharma marketers are taking a more cautious approach to implementing the technology. In interviews with Fierce Pharma Marketing at Fierce’s annual Digital Pharma East event in Philadelphia last week, marketing leaders from Bayer, Daiichi Sankyo and argenx discussed that slower integration of AI as well as the many opportunities for the technology in the realm of pharma marketing.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article